concept

AND

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AND: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

11657Connections
24Hypotheses
30Analyses
50Outgoing
50Incoming

No summary available yet. View on Wiki →

💡 Concept Info
NameAND
Key Genes/ProteinsPS1
Related DiseasesAlzheimer's disease, neurodegeneration, Atherosclerosis, Cancer, Als
Related Pathwaysoxidative stress response, apoptosis pathway, ubiquitin-proteasome
Linked Hypotheses41 hypotheses

Wiki Pages (20)

Knowledge base pages for this entity

cbs-psp-daily-action-plan

therapeutic · 30834 words

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

therapeutic · 15567 words

Clinical Management Guide for CBS/PSP

therapeutic · 15224 words

Progressive Supranuclear Palsy (PSP)

disease · 12907 words

Pathway Diagram

graph TD
    subgraph Interactions["Interactions"]
        AND["AND"] -->|"participates in"| oxidative_stress_response["oxidative stress response"]
        AND["AND"] -->|"participates in"| apoptosis_pathway["apoptosis pathway"]
        AND["AND"] -->|"interacts with"| Alzheimer_s_disease["Alzheimer's disease"]
        AND["AND"] -->|"participates in"| ubiquitin_proteasome["ubiquitin-proteasome"]
        TP53["TP53"] -->|"interacts with"| AND["AND"]
        APOPTOSIS_2["APOPTOSIS"] -->|"interacts with"| AND["AND"]
    end
    subgraph Therapeutic["Therapeutic"]
        AND["AND"] -->|"expressed in"| endothelial_cells["endothelial cells"]
    end
    subgraph Pathology["Pathology"]
        AND["AND"] -->|"associated with"| Alzheimer_s_disease_1["Alzheimer's disease"]
        AND["AND"] -->|"associated with"| neurodegeneration["neurodegeneration"]
        AND["AND"] -->|"associated with"| PS1["PS1"]
        AND["AND"] -->|"associated with"| Atherosclerosis["Atherosclerosis"]
        MYC["MYC"] -->|"associated with"| AND["AND"]
        JUN["JUN"] -->|"associated with"| AND["AND"]
        APOPTOSIS["APOPTOSIS"] -->|"associated with"| AND["AND"]
    end
    subgraph Signaling["Signaling"]
        CYTOKINES["CYTOKINES"] -->|"activates"| AND["AND"]
    end
    style AND fill:#90a4ae,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
    style oxidative_stress_response fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style apoptosis_pathway fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style endothelial_cells fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Alzheimer_s_disease fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Alzheimer_s_disease_1 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style neurodegeneration fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style PS1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ubiquitin_proteasome fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Atherosclerosis fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style TP53 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style MYC fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style JUN fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style APOPTOSIS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style CYTOKINES fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style APOPTOSIS_2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0

Outgoing (6188)

TargetRelationTypeStr
oxidative stress responseparticipates_inpathway0.90
apoptosis pathwayparticipates_inpathway0.80
endothelial cellsexpressed_incell_type0.80
Alzheimer's diseaseinteracts_withdisease0.70
Alzheimer's diseaseassociated_withdisease0.70

Incoming (5469)

SourceRelationTypeStr
TP53interacts_withgene0.60
MYCassociated_withgene0.60
JUNassociated_withgene0.60
APOPTOSISassociated_withgene0.60
CYTOKINESactivatesgene0.60

Targeting Hypotheses (24)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Closed-loop tACS targeting EC-II SST interneurons to block t 0.697 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop focused ultrasound targeting EC-II SST interneur 0.697 Alzheimer's disease Circuit-level neural dynamics in neurode
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna 0.677 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II PV interneurons to suppress 0.670 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II parvalbumin interneurons to 0.660 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop optogenetic targeting PV interneurons to restore 0.633 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop tACS targeting entorhinal cortex layer II SST in 0.625 Alzheimer's disease Circuit-level neural dynamics in neurode
p38α Inhibitor and PRMT1 Activator Combination to Restore Ph 0.615 neurodegeneration What is the therapeutic window between i
Closed-loop focused ultrasound targeting CA1 PV interneurons 0.614 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound targeting EC-II 0.612 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II PV interneurons to enhance 0.578 Alzheimer's disease Circuit-level neural dynamics in neurode
HDAC6 Selective Inhibition to Restore Acetylation Balance an 0.577 structural biology What is the atomic-resolution structure
Closed-loop focused ultrasound targeting EC-II PV interneuro 0.568 Alzheimer's disease Circuit-level neural dynamics in neurode
PARP1 Inhibition Blocks Poly(PR)-Triggered DNA Damage and Su 0.562 neurodegeneration What upstream mechanisms trigger p53 act
TNF-α/IL-1β-Cx43 Hemichannel Axis as Upstream Link Between S 0.548 cell biology What is the relative contribution of con
ABCA7-TREM2 Co-Targeting for Microglial Lipid Handling 0.538 neurodegeneration Why does the V1613M variant reduce amylo
Vascular mural cell degeneration precedes and exacerbates pa 0.520 Alzheimer's disease SEA-AD Single-Cell Analysis: Cell-Type V
Closed-loop transcranial focused ultrasound targeting CA1 PV 0.508 Alzheimer's disease Circuit-level neural dynamics in neurode
LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferrop 0.493 Alzheimer's Disease Cell type vulnerability in Alzheimers Di
LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Sub 0.491 Alzheimer's Disease Cell type vulnerability in Alzheimers Di
TREM2-APOE4 Co-targeting — Simultaneous Correction of Lipid 0.486 Alzheimer's disease TREM2 agonism vs antagonism in DAM micro
LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vul 0.485 Alzheimer's Disease Cell type vulnerability in Alzheimers Di
HDAC6 Inhibition for Dual Restoration of Microtubule Stabili 0.459 neurodegeneration Which tau PTMs are both disease-specific
Multi-Modal CRISPR Platform for Simultaneous Editing and Mon 0.423 neurodegeneration CRISPR-based therapeutic approaches for

Mentioning Analyses (30)

Scientific analyses that reference this entity

What molecular mechanisms mediate SPP1-induced microglial phagocytic activation

neuroinflammation | 2026-04-15 | 1 hypotheses Top: 0.650

What is the temporal sequence of TREM2 signaling transition from protective to i

neuroimmunology | 2026-04-15 | 2 hypotheses Top: 0.674

Do CXCL10-recruited CD8+ T cells provide neuroprotection or cause damage in agin

neuroimmunology | 2026-04-15 | 1 hypotheses Top: 0.514

What are the precise temporal dynamics of astrocyte ketone production decline du

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.645

How does engineered C. butyricum cross the blood-brain barrier to directly bind

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.675

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Antidepressant effects of combined eucommia-gastrodia extract via modulation of [PMID:41921863] Xue L, Pan Z, Liu Y, Gan Q, Liu D, Liu D Brain research bulletin 2026 0
Complementary mechanisms of high-carbohydrate diets and ketogenic diets restore [PMID:41475465] Kwon H, Seo DS, Ahmad Y, Park S, Yoo J, The Journal of nutritional bio 2026 0
TrkB promotes the neuronal secretion of soluble Siglec-2 (CD22) to mitigate micr [PMID:41922794] Shi X, Cai SZ, Chai JL, Xu CY, Zhou BY, Molecular psychiatry 2026 0
The Potential Functions and Beneficial Effects of Melatonin on Cognitive Impairm [PMID:41917799] Li XY, Cheng YZ, Zhang YM, Hu F, Fang SK Brain and behavior 2026 0
Biomarkers for Alzheimer's disease across diverse biological domains: an umbrell [PMID:40680830] Kang J, Son Y, Yim Y, Cho H, Kim J et al J Adv Res 2026 0
Nanotherapeutic potential of Baicalein-encapsulated hUC-MSC exosomes in Alzheime [PMID:41370943] Xu J, He Z, Pan Y, Cao B, Chen G Biomater Adv 2026 0
Zhi-Gan Formula improved insomnia and anxiety comorbidity in a mouse model via P [PMID:41525914] Liu R, Wu Z, Yin Y, Song C, Zhang C et a J Ethnopharmacol 2026 0
Triterpenoid saponins from Platycodon grandiflorus exhibit antidepressant-like e [PMID:41539634] Yoon S, Chun E, Iqbal H, Kim SH, Kim SY J Ethnopharmacol 2026 0
Epigenetic mechanisms and therapeutic innovations in chronic pain-associated neu [PMID:41554641] Zhang K, Zhu S, Xing N, Zhou Z, Chen J e Br J Pharmacol 2026 0
Postbiotics and the gut-brain axis: A mechanistic review on modulating neuroinfl [PMID:41570486] Lahariya R, Anand G, Kumari B, Priyadars J Neuroimmunol 2026 0
miRNA-206 in muscle and central nervous system crosstalk during exercise: A doub [PMID:41571168] Malvandi AM, Gerosa L, Maroni P, Orlando Neurosci Biobehav Rev 2026 0
Experts' narrative review "Mastication, Hippocampal Structure Changes and Cognit [PMID:41576846] Piancino MG Arch Oral Biol 2026 0
Plant-derived bioactive compounds modulate the gut microbiota in Alzheimer's dis [PMID:41678917] Xue D, Hu X, Li R, Sun T, Qian S et al. Phytomedicine 2026 0
Dysregulation of Drp1 and Mfn2 is associated with reduced PSD-95, synaptophysin, [PMID:41932483] Alfateh M, Vasconcelos C, Choker AH, Moh Int J Biol Macromol 2026 0
AICAR improves depression-like behaviors and is associated with hippocampal AMPK [PMID:41932583] Takahashi K, Kurokawa K, Kawaguchi R, Ta Neurochem Int 2026 0
Designed Liquid Crystalline Nanoassemblies From Clinically Validated Polyunsatur [PMID:41937329] Akanchise T, Luo F, Angelov B, Deng Y, A Adv Healthc Mater 2026 0
Single transient exposure to low-frequency low-intensity electrical stimulation [PMID:41942002] Marcotto GS, Borghetti M, Bitraj J, Cava Neuropharmacology 2026 0
Serpina1e mediates the exercise-induced enhancement of hippocampal memory in mal [PMID:41957371] Kim H, Shin S, Han J, Yun K, Kim JS et a Nat Commun 2026 0
Ubiquinol Ameliorates Social Disruption-induced Behavioral Changes via Modulatin [PMID:41962635] Chen CW, Huang BR, Yeh WL, Huang SS, Cha Behav Brain Res 2026 0
Dietary Advanced Glycation End Products Induced Anxiety- and Depression-like Beh [PMID:41962780] Ma T, He Z, Yang G, Cai J, Qin LQ et al. J Nutr Biochem 2026 0